Sarcopenia and Combined-modality Exercise
- Conditions
- Sarcopenia
- Registration Number
- NCT04806152
- Lead Sponsor
- The University of The West Indies
- Brief Summary
This study examined the effects of combined-modality exercise training (resistance, endurance, flexibility and balance) on muscle mass, muscle function and physical activity in community-dwelling elderly living in Jamaica who had been characterised as having sarcopenia.
- Detailed Description
Community-dwelling seniors aged 60 years and older were screened for muscle mass and function (grip strength and walk speed) and persons with sarcopenia were identified using the European Working Group on Sarcopenia in Older Persons (EWGSOP) algorithm for case finding (N=1344). Of the 77 seniors with sarcopenia, 38 consented to participate and were randomly allocated to receive 6 months combined-modality high intensity treadmill based exercise and a 'usual care' home exercise programme. A comparison of the effects of treatment assignment on muscle mass, function, fitness, physical activity level and disability was done. Participants in the supervised combined-modality high intensity group were required to attend sessions 3 times per week; participants in the home exercise programme were required to attend 1 supervised session at the start of their 6-month intervention. Outcomes were assessed at baseline and at the end of the 6-month intervention. Data were analysed using standard statistical parametric and non-parametric methods including repeated measures analysis of variance to determine changes in outcomes and regression to establish determinants of outcomes.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 38
- over 60 years old,
- independently ambulant, with or without an assistive device
- mentally competent to give informed consent and follow exercise instructions
- a history of stroke with residual disability
- a diagnosis of cancer
- neuromuscular disorders
- auto-immune disorders
- dementia
- severe arthritis rendering participation in an exercise programme difficult
- unstable cardiovascular disease which renders exercise unsafe
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Lower extremity (LE) functional strength 6 months 1-repetition maximum (RM) strength
Appendicular lean mass index 6 months dual energy x-ray absorptiometry (DEXA) measured appendicular lean mass summed and divided by height squared, expressed in kg/m2
Disability 6 months Lawton Instrumental Activities of Daily Living scale: minimum score = 0 (low function, dependent); maximum score = 8 (high function, independent). Lower scores indicate a worse outcome.
Fat-free mass 6 months dual energy x-ray absorptiometry (DEXA) determined: fat mass subtracted from weight, expressed in kg
self-selected walk speed 6 months speed in the timed-10-metre walk
Accelerometry 6 months weekly energy expenditure
Balance 6 months Berg balance test score: minimum score = 0, maximum score = 56. Lower values indicate worse outcome
Functional endurance 6 months Distance walked in 6 minutes
- Secondary Outcome Measures
Name Time Method Depression 6 months Center for Epidemiological Studies-Depression \[CES-D\] score: minimum score = 0, maximum score = 60, with higher scores indicating more depressive symptoms
Timed-up-and-go 6 months Functional test indicating fall risk
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
UWI Solutions for Developing Countries (SODECO)
🇯🇲Kingston 7, KSA, Jamaica
UWI Solutions for Developing Countries (SODECO)🇯🇲Kingston 7, KSA, Jamaica